Accepted for/Published in: JMIR Nursing
Date Submitted: Apr 15, 2019
Open Peer Review Period: Apr 23, 2019 - Jun 5, 2019
Date Accepted: Jun 23, 2019
(closed for review but you can still tweet)
Needs and barriers of medication taking self-efficacy among post-stroke patients: a qualitative study
ABSTRACT
Background:
Stroke is one of the top ten leading diseases with high mortality and morbidity rate globally. There is an incomplete understanding of various types of self-efficacy involved in recurrent stroke prevention, and one of them is medication taking self-efficacy.
Objective:
Therefore the present study explores its fundamental needs and barriers.
Methods:
We report here findings from in-depth individual interviews with ten post-stroke patients from the Outpatient and Inpatient Neurology clinic, Hospital Kuala Lumpur.
Results:
Two key themes were identified, 1) self-efficacy in understanding recurrent stroke and its preventative treatment and 2) self-efficacy in taking prescribed medication. The discussion was focused on eliciting the needs and barriers related to medication taking self-efficacy.
Conclusions:
The study findings were consistent with several health behavioral concepts and constructs, indicating the importance of understanding needs and overcoming barriers to improve quality of life of post-stroke patients. We anticipate that, the results would be into consideration for future patient education intervention. Clinical Trial: The design and conduct of the study approvals have been granted by the Malaysian Medical Research and Ethics Committee – MREC (NMRR ID-15-851-24737) in July 2015.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.